Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of PYM50028 administered once daily for up
to 12 weeks on the memory and other faculties of subjects with dementia due to Alzheimer's
disease.